Occurrence of suppurative lymphadenitis after a change of BCG vaccine.
暂无分享,去创建一个
[1] P. Saliou,et al. Comparative trial of administration of half (0.05 mg) and quarter (0.025 mg) dose of intradermal Pasteur BCG on 291 infants from birth to 1 year in French Guyana. , 1991, Vaccine.
[2] P. Hengster,et al. Suppurative lymphadenitis in newborn babies after change of BCG vaccine , 1991, The Lancet.
[3] M. Lallemant,et al. Bacillus Calmette-Guérin immunization in infants born to HIV-1-seropositive mothers. , 1991, AIDS.
[4] P. Epstein. BCG vaccination and nutrition , 1990, The Lancet.
[5] J. Gibson,et al. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. , 1990, Bulletin of the World Health Organization.
[6] P. Fine. The BCG story: lessons from the past and implications for the future. , 1989, Reviews of infectious diseases.
[7] U. Bollag,et al. [Tuberculin reaction and the extent of the vaccination scar following BCG vaccination in newborn infants]. , 1988, Schweizerische medizinische Wochenschrift.
[8] G. Packe,et al. Protective effect of BCG vaccination in infant Asians: a case-control study. , 1988, Archives of disease in childhood.
[9] O. Yeǧin,et al. Is medical therapy effective for regional lymphadenitis following BCG vaccination? , 1987, American journal of diseases of children.
[10] T. Myint,et al. Case-control study on evaluation of BCG vaccination of newborn in Rangoon, Burma. , 1987, Annals of tropical paediatrics.
[11] V. Romanus. Tuberculosis in Bacillus Calmette-Guérin-immunized and unimmunized children in Sweden: a ten-year evaluation following the cessation of general Bacillus Calmette-Guérin immunization of the newborn in 1975. , 1987, The Pediatric infectious disease journal.
[12] T. Giger,et al. [BCG osteitis in Switzerland. A report of 6 cases]. , 1987, Schweizerische medizinische Wochenschrift.
[13] H. G. ten Dam,et al. The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. , 1986, Tubercle.
[14] E. Hershfield,et al. A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians. , 1986, American journal of public health.
[15] Mahmoud Me,et al. Evaluation of BCG vaccination in Bab El Shaaria zone--Cairo. , 1986 .
[16] M. E. Mahmoud,et al. Evaluation of BCG vaccination in Bab El Shaaria zone--Cairo. , 1986, Developments in biological standardization.
[17] G. Nyerges,et al. Significance of the number of viable units in BCG vaccines. , 1986, Developments in biological standardization.
[18] U. Stephan,et al. [BCG vaccination of the newborn infant with the 131 Copenhagen strain]. , 1986, Klinische Padiatrie.
[19] Celia Davies,et al. The Role of Medicine: Dream, Mirage or Nemesis? , 1978 .
[20] W. Brehmer,et al. [Regional suppurative lymphadenitis after BCG vaccination (author's transl)]. , 1977, Deutsche medizinische Wochenschrift.